Breaks Categories: Analyst Alerts

MondayAug 17, 2020 12:54 pm

NetworkNewsBreaks – Analysis Report Compares Major US Airlines

Southwest Airlines Co. (NYSE: LUV), United Airlines Holdings, Inc. (NASDAQ: UAL), Delta Air Lines (NYSE: DAL) and American Airlines Group Inc. (NASDAQ: AAL) were featured in a recent analysis report comparing major US airlines. The report, written by LikeFolio Founder Andy Swan, reads, “After recording a 96% reduction in U.S. airline passengers in April (YoY), the tide is shifting.. For investors, it's helpful to understand how the airlines are responding. We're looking at sentiment specifically...which is often a long-leading indicator of which companies are best positioned to capture market share in a recovery. Here's how sentiment stacks up...” About LikeFolio…

Continue Reading

FridayAug 14, 2020 3:16 pm

NetworkNewsBreaks – Square, Inc. (NYSE: SQ) Featured in Analysis Report

Square (NYSE: SQ), an American aggregator of financial and merchant services, was featured in an analysis report discussing the company’s recent release of financial results for the second quarter of 2020. The report, written by LikeFolio Founder Andy Swan, reads, “After a surprise early earnings release (reporting 64% revenue growth) SQ shares surged. Users flooded into Cash App. Profit increased 167% and revenue from Bitcoin increased 600%. You can see this surge in consumers using Cash App as an investment tool on the chart below, heavily tilted to Bitcoin mentions. Overall demand for Square products increased +92% in the last…

Continue Reading

FridayAug 14, 2020 2:59 pm

NetworkNewsBreaks – Roku, Inc. (NASDAQ: ROKU) Featured in Analysis Report

Roku (NASDAQ: ROKU) was featured in a recent analysis report that detailed the recent increase in online mentions of consumers buying or using a Roku-powered device. The report, written by LikeFolio Founder Andy Swan, reads, “Roku Purchase Intent Mentions increased +47% YoY in 20Q2 and continue to climb. . .  Ads and commission revenue grew 3.3x from 2017 to 2019, and is expected to grow significantly in 2020. However, short-term ad revenues may not meet expectations due to an decline in ad spend across the board in Q2.” About Roku Roku pioneered streaming to the TV. It connects users to…

Continue Reading

WednesdayAug 12, 2020 10:09 am

NetworkNewsBreaks – Satsuma Pharmaceuticals, Inc. (NASDAQ: STSA) Featured in Mizuho Securities Research Report

Satsuma Pharmaceuticals (NASDAQ: STSA) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “Satsuma reported 2Q20 earnings that were close to Street expectations with a net loss of ($11.3M) (vs. Mizuho at ($12.7M) and consensus at ($12.8M)), and EPS of ($0.65) (vs. Mizuho at ($0.69) and consensus at ($0.73)). More importantly for a clinical-stage company such as Satsuma is the progress they are making with their pipeline, and all parts of the STS101 program appear on track. The company recently announced completion of the treatment phase of the Phase 3 EMERGE trial…

Continue Reading

TuesdayAug 11, 2020 1:19 pm

NetworkNewsBreaks – Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) Featured in Mizuho Securities Research Report

Biohaven Pharmaceutical Holding Company (NYSE: BHVN) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “We are updating our Biohaven model after 2Q20 earnings, accounting for the results and the recently announced financing agreement with Royalty Pharma (RPRX; Not Covered) and term loan with Sixth Street to support Nurtec ODT's ongoing launch and the development of zavegepant. We believe these agreements provide attractive forms of financing that obviate the near-term need for additional capital raise, while allowing Biohaven to compete in the migraine market. Nurtec's uptake continues to impress us, and we…

Continue Reading

TuesdayAug 11, 2020 1:11 pm

NetworkNewsBreaks – Revance Therapeutics, Inc. (NASDAQ: RVNC) Featured in Mizuho Securities Research Report

Revance Therapeutics (NASDAQ: RVNC) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “We are assuming coverage of Revance Therapeutics with a Buy rating and $32 PT (from $35). We see the aesthetics market as an attractive one over the long term, despite the significant challenges and uncertainty it is facing given the ongoing COVID-19 pandemic. We forecast a slow launch for both Daxi and Revance’s RHA Collection dermal filler line, but expect enough positive progress, along with positive data from therapeutic indications, for continued stock appreciation. Our estimates are guided by…

Continue Reading

MondayAug 10, 2020 2:23 pm

NetworkNewsBreaks – Sage Therapeutics, Inc. (NASDAQ: SAGE) Featured in Mizuho Securities Research Report

Sage Therapeutics (NASDAQ: SAGE) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “Sage reported 2Q20 results this morning, with focus on the progress they are making with their pipeline, most notably zuranolone, more than the financial performance. Higher R&D expenses led to a $3M greater net loss than we had expected, but positive developments include the start of two Phase 3 trials for zuranolone (in PPD and episodic treatment of MDD), with the acute RRT trial on track to start later this year. Six-month open-label follow-up from the MOUNTAIN trial shows…

Continue Reading

FridayAug 07, 2020 11:34 am

NetworkNewsBreaks – Beyond Meat, Inc. (NASDAQ: BYND) Featured in Analysis Report

Beyond Meat (NASDAQ: BYND), a food company that provides plant-based meat, was recently featured in an analysis report discussing the how it has been affected by the COVID-19 pandemic. The report, written by LikeFolio Founder Andy Swan, reads, “As consumers eat out less and instead fill pantries (and refrigerators), BYND is adjusting and attempting to beef up retail production to offset potential foodservice declines. (Last quarter, retail sales comprised ~58% of revenue). LikeFolio data reveals waning demand: -52% YoY.” About Beyond Meat Beyond Meat, Inc. (NASDAQ: BYND) is one of the fastest growing food companies in the United States, offering…

Continue Reading

FridayAug 07, 2020 11:19 am

NetworkNewsBreaks – Take-Two Interactive Software, Inc. (NASDAQ: TTWO) Featured in Analysis Report

Take-Two Interactive Software (NASDAQ: TTWO) was featured in a recent analysis report that detailed the company’s rising purchase intent mentions as consumers stayed home during COVID-19 lockdowns. The report, written by LikeFolio Founder Andy Swan, reads, “TTWO is being propelled by significant consumer trends. Generic gaming mentions are up 49% in the last month vs. prior year and NEW gamers are entering the market...first time gaming mentions are up 155% in the last month vs. prior year. Market expectations are extremely high. TTWO is up 37% YTD, and revenues are expected to increase 95% YoY on this report. We'll be…

Continue Reading

FridayAug 07, 2020 10:09 am

NetworkNewsBreaks – Satsuma Pharmaceuticals, Inc. (NASDAQ: STSA) Featured in Mizuho Securities Research Report

Satsuma Pharmaceuticals (NASDAQ: STSA) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “STS101 EMERGE Phase 3 Data Expected in September/October 2020: In a press release after the close, Satsuma announced the start of patient enrollment in the open-label ASCEND Phase 3 study that is expected to provide long-term safety data to support FDA filing for its flagship asset STS101 (dihydroergotamine nasal spray) for treating acute migraine. More importantly, the company also disclosed that patient treatment has been completed in the Phase 3 EMERGE efficacy study, with results expected in late September…

Continue Reading